Next Generation Point-of-Care Biosensing Device
Aston University, West Midlands, United Kingdom
Early diagnostic information is crucial to providing early and appropriate antibiotic intervention. The innovation is a next generation point-of-care testing device that offers order-of-magnitude improvements (cost, speed, convenience, ease-of-use) to the diagnosis of microbial infections and other diseases. The innovation uses patent-pending microplate technology fabricated using standard semiconductor techniques.
Primary Application Area: Biotech & Biological Sciences
Technology Development Status: Concept
Technology Readiness Level: TRL 2
FIGURES OF MERIT
Value Proposition: This technology promises order-of-magnitude improvements in cost per test, the time necessary for obtaining results, convenience and ease-of-use. It is a relatively simple technology that is fabricated using standard semiconductor techniques, and could be easily adapted to integrate with mobile computing platforms.
Organization Type: Academic/Gov Lab
Showcase Booth #: 652
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: Development was supported by the UK government via EPSRC.
Primary Sources of Funding: University, Other
Looking for: Both Funding and Development Partners